RightFit
RecruitingPhase not listed

The RADIANCE CED Study

The Recor Paradise System™ Hypertension Coverage With Evidence Development Study

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
65 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Ultrasound

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

The RADIANCE CED study looks at how well ultrasound renal denervation lowers blood pressure over time. This treatment uses ultrasound to treat nerves near the kidneys. The study uses health records of adults age 65 or older who qualify for Medicare and have high blood pressure that is not controlled.

The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Age 65 or older with high blood pressure that is not controlled.
  • Taking blood pressure medicines on a stable schedule, without changes.

Who can't join

  • High blood pressure caused by another health condition.
  • Past renal denervation treatment, which treats nerves near the kidneys.
  • Pregnant.
  • Kidney failure, dialysis (treatment to filter the blood), or a kidney transplant.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Common Inclusion Criteria: * Adults aged ≥65 years with uncontrolled hypertension * Stable regimen of blood pressure-lowering medication Common Exclusion Criteria: * Hypertension due to secondary causes * Prior renal denervation treatment * Pregnancy * End-stage renal disease, dialysis, or kidney transplant

Study sites (2)

MI